Brief: Oncopeptides Withdraws Pepaxto In US

Oncopeptides AB

22/10/2021 14:00

Oct 22 (Reuters) - Oncopeptides AB  ONCO.ST :
    * ONCOPEPTIDES WITHDRAWS PEPAXTO®[ ]IN US, SCALE DOWN
ORGANIZATION
AND FOCUS ON RESEARCH AND DEVELOPMENT
    * DECIDED TO WITHDRAW PEPAXTO®(INNMELPHALAN FLUFENAMIDE)FROM
MARKET IN US, FOLLOWING PHASE 3 OCEAN STUDY
    * COMPANY EXPECTS TO RECEIVE A CHMP OPINION IN Q2, 2022.

Source text for Eikon:  ID:nWkr6xCL3S 
Further company coverage:  ONCO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))